ERBB3 and breast carcinoma: For example, expression of multiple members of the epidermal growth factor receptor family (HER1, HER2, or HER3) and estrogen receptor is present in most breast cancer cells, and these receptors have all been shown to activate the MEK-ERK pathway[43–45].